Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 289.17K |
Day Range | - - - |
52 Wk Range | 12.54 - 28.20 |
Market Cap | $1.65B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 4.77% |
Days to Cover | 8.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX), CareDx (NASDAQ:CDNA), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
Bicycle Therapeutics has a consensus price target of $43.31.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $23.97 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.